This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Yusuf Erkul, M.D
Co-founder & President at Kernal Biologics


Yusuf Erkul is the co-founder and president of Kernal Biologics, a Cambridge-based biotech startup developing next generation messenger RNAs for cancer immunotherapy. As a member of MIT Startup Exchange, Kernal received two Golden Ticket awards from Amgen and a "Technology in Space" prize from CASIS/NASA and Boeing. Dr. Erkul co-invented Kernal's proprietary stealth mRNA and onco-selective mRNA technologies. With his expertise in nucleic acid therapeutics, innate immunity and cancer biology, Dr. Erkul is currently leading Kernal's drug discovery and development efforts in immuno-oncology. Previously, he was a Director at Sentegen's R&D division and prior to that he worked at Merck's Oncology department, where he received Merck's Award of Excellence, twice. Dr. Erkul obtained his M.D. degree from Hacettepe University and his B.S. degree in Biology from MIT.

Agenda Sessions

  • Precisely Engineered Stealth mRNAs for Oncolytic mRNA Immunotherapy